About ROWE Partners
ROWE Partners is an accelerator and incubator program based in Daejeon, South Korea. With a presence in 1 country, it has supported around 21 startups in sectors like Enterprise Applications, High Tech. Most notable companies in
its portfolio include CN AI, Connect Fit and Pebblous. The program is backed by a team of 3 people who primarily support startups based in South Korea.
Key Metrics
ROWE Partners' List of Top Investments
ROWE Partners has a portfolio of 21 companies. Their most notable investments include CN AI and Connect Fit.Their portfolio spans across and South Korea. They have invested in Enterprise Applications, High Tech, Life Sciences and 12 other sectors. Here is the list of top investments by ROWE Partners:
1. CN AI
Key facts about CN AI
- Founded Year: 2021
- Location: Seongdong (South Korea)
- Stage: Series A
- Total Funding till date: $4.1M
- Employee Count: 21 as on May 31, 2026
- Investors: MDI Ventures, Centauri Fund and 2 Others
- Latest Funding Round: Series A, Apr 21, 2022, $*****
- Highlight: Editors' Pick
2. Connect Fit
Online platform for workers to manage work schedules and calculate wages. It provides employers with platforms to help their employees invest their savings through various investment providers. Its features include a financial service app that provides migrant workers to manage work schedules and calculate wages.
Key facts about Connect Fit
- Founded Year: 2020
- Location: Seoul (South Korea)
- Stage: Funding Raised
- Employee Count: 6 as on May 31, 2026
- Investors: ROWE Partners
3. Pebblous
AI-based data research and development solutions provider. It offers a data clinic pipeline that includes data imaging, diagnosis, and therapy modules for the generation and assessment of large data.
Key facts about Pebblous
- Founded Year: 2021
- Location: Daejeon (South Korea)
- Stage: Funding Raised
- Employee Count: 13 as on May 31, 2026
- Investors: Kite Entrepreneurship Foundation and ROWE Partners
Developer of radiopharmaceuticals for cancer diagnosis and treatment. It offers a nano platform TERACARRIER that developes magnetic nanometer material that removes cancer cells. It also has Zhyper-X, a fully-automated miniaturized radiopharmaceutical manufacturing device.
Key facts about ZTI BIOSCIENCES
- Founded Year: 2020
- Location: Suwon-si (South Korea)
- Stage: Funding Raised
- Employee Count: 16 as on May 31, 2026
- Investors: Kiwoom Investment and ROWE Partners
Developer of invitro diagnosis device for urine analysis. The company focuses on the development of medical devices which include the 'next-generation urine analyzer' an in vitro diagnostic medical device to detect urine infections that can provide precise test results.
Key facts about DNC Biotechnology
- Founded Year: 2021
- Location: Seoul (South Korea)
- Stage: Funding Raised
- Investors: Mirae Science and Technology Holdings and ROWE Partners
Team profile of ROWE Partners
ROWE Partners has a team of 3 members including 3 Partners. ROWE Partners' team does not sit on the board of any company as of now.Here is a list of all team members in ROWE Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - |
